Strength

20; 5 mg/mL; mg/mL

NDC

69315030510

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205295

On Market Since

5/18/2017

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

-1.0%

3M

-1.0%

6M

-6.7%

1Y

-20.2%

3Y

-15.7%

5Y

N/A

All

-40.6%